General Info

Cubist Pharmaceuticals is a biopharmaceutical company focused on the research, development and commercialization of products that address unmet medical needs in the acute care environment. Cubist has been exclusively focused on developing business and product opportunities in the anti-infective market place. In addition, the U.S. Food and Drug Administration approved Cubicin, the company s flagship drug, on September 12, 2003, for sale in the United States. Cubist is headquartered in Lexington, Mass., and was founded in 1996.